The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 14.00
Ask: 15.40
Change: -2.95 (-16.71%)
Spread: 1.40 (10.00%)
Open: 16.00
High: 16.40
Low: 14.00
Prev. Close: 17.65
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

Tue, 02nd Nov 2021 15:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

UP Global Sourcing Holdings PLC - Oldham, Greater Manchester-based consumer brands owner - For the year ended July 31, pretax profit rises 14% to GBP9.5 million from GBP8.4 million the year before, on revenue which increases 18% year-on-year to GBP136.4 million from GBP115.7 million, with consumer behaviour changing to home cooking and working fostering growth from the Small Domestic Appliances, Homewares and Laundry segments. Declares total dividend of 5.020 pence per share, up 27% from 3.955p the year before. Looking ahead, current trading is in line with expectations, despite global shipping set to remain disrupted until February next year.

----------

Beximco Pharmaceuticals Ltd - Bangladesh-based pharmaceutical company - For the year ended June 30, pretax profit rises 37% to BDT6.38 billion, around GBP54.7 million, up 37% from BDT4.65 billion, on revenue which grows 15% year-on-year to BDT29.49 billion from BDT25.61 billion, driven by double digit growth in both domestic and export sales, with the launch of 22 new products domestically. Proposes dividend of BDT3.5 per share.

----------

Triad Group PLC - Godalming, England-based software company - For the six months ended September 30, pretax profit surges to GBP67,000 from GBP1,000 a year before, with gross profit rising 54% to GBP2.3 million, driven by a focus on the group's consulting services. However, revenue drops 1.1% year-on-year to GBP8.6 million from GBP8.7 million. Proposes interim dividend of 2.0 pence per share, from none a year prior. Looking ahead, expects second half to see high utilisation levels and an increase in headcount in response to persistent demand.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - During the third quarter of 2021, content licensing revenue rises 35% year-on-year, alongside growth in the new licensing and games pipeline. In addition, has been approved for a full iGaming Supplier Licence in Michigan.

----------

Eckoh PLC - London-based secure payment products provider - For the six months ended September 30, company performs in line with management expectations, with underlying revenue slightly higher, and operating profit rising 18%. However, total revenue was slightly lower at constant currency, due to the company's planned exit from US and UK third-party support. Looking ahead, expects performance for the full year to meet market expectations.

----------

Argo Blockchain PLC - London-based cryptocurrency miner - For the three months ended September, reports pretax profit at USD24.6 million on revenue at a record figure of USD26.0 million. During the quarter, the company mined 597 bitcoin and bitcoin-equivalent, bringing Argo's total to 1,836 as at the end of September.

----------

Shearwater Group PLC - London-based cybersecurity provider - For the six months ended September 30, expects underlying earnings before interest, tax, depreciation and amortisation to rise 19% to GBP1.3 million from GBP1.1 million a year before, due to an increasing proportion of higher margin software. Revenue, however, is set to decline 5.4% year-on-year to GBP10.6 million from GBP11.2 million.

----------

GRC International Group PLC - supplier of cyber security, risk management and compliance products - For the six months ended September 30, total billings up 26% at 6,670 from 5,583 a year before, due to continued momentum from the second half of the prior year. As a result, achieves positive earnings before interest, tax, depreciation and amortisation for the period. Look ahead, trading in October has been in line with management expectations.

----------

Watkin Jones PLC - London-based student accommodation developer and manager - For the year ended September 30, expects operating profit to be in line with expectations, on revenue forecast at GBP430 million, slightly below expectations, but up 21% from GBP354.1 million the year before.

----------

Warpaint London PLC - Buckinghamshire-based cosmetics maker - For 2021, expects sales to be at similar levels to those in 2019, which was at GBP49.3 million. For 2020, sales reached GBP40.3 million. This is due to growth from new and existing customers, despite Covi-19 disruption. Expects adjusted earnings before interest, tax, depreciation and amortisation and adjusted pretax profit to be both ahead of 2019 and current market expectations. Adjusted Ebitda in 2019 was GBP7.0 million and adjusted pretax profit was GBP5.2 million.

----------

Feedback PLC - medical imaging software company - For the year ended May 31, pretax loss widens to GBP2.1 million from GBP1.4 million the year before, on revenue which declines 36% year-on-year to GBP290,000 from GBP450,000, reflecting the planned move away from legacy products and a focus on Bleepa, and the loss is exacerbated by an expanded headcount. Also raises GBP10.7 million through a placing of 1.53 billion shares at a price of 0.7 pence each. "Funds raised will be used primarily to support accelerated revenue growth through both private and public healthcare revenue opportunities within both the NHS and other healthcare systems in the UK and overseas," it says. Will also look to raise an additional GBP500,000 via an open offer to eligible shareholders.

----------

Oncimmune Holdings PLC - Nottingham, England-based diagnostics company - For the year ended May 31, pretax loss narrows to GBP5.7 million from GBP9.8 million the year before, on revenue which soared to GBP3.7 million from GBP509,000, driven by a rise in the number of contracts awarded, leading to the growth of the ImmunoINSIGHTS' business. Looking ahead, due to growth from ImmunoINSIGHTS, company expects profitability and cash generation to improve. Notes "quieter than expected summer months" in which fewer new ImmunoINSIGHTS contracts were signed than originally expected, but says there has been healthy resumption of activity.

----------

Rutherford Health PLC - Hereford, England-based cancer care centre provider - For the six months ended August 31, pretax loss widens to GBP19.9 million from GBP15.7 million a year prior due to higher expenses, particularly employee costs and preparation for the opening of the first Rutherford Diagnostics Centre in Somerset. Revenue however rises 36% year-on-year to GBP4.9 million from GBP3.6 million, due to the group's expansion within Diagnostics, and a rise in SACT treatments across all centres.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 May 2019 15:27

Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.

Read more
10 May 2019 12:59

Oncimmune begins study to bring 'EarlyCDT-Lung' to China

(Sharecast News) - Oncimmune Holdings, alongside its partner Genostics Company, announced the start of a multi-centre case control study on early lung cancer detection for screening and nodules in the People's Republic of China on Friday, using an extended panel of autoantibodies to accommodate variations in the biomarkers expressed on cancer cells in Asian populations.

Read more
10 May 2019 11:36

Oncimmune And Genostics Initiate Trial Of EarlyCDT-Lung In China

LONDON (Alliance News) - Oncimmune Holdings PLC and Genostics Co Ltd on Friday said a multi-centre case control study on early lung cancer detection in China has started.The company said is

Read more
5 Apr 2019 15:10

Oncimmune inks distribution deal for lung cancer test in Portugal

(Sharecast News) - Personalised immunodiagnostics developer Oncimmune Holdings has signed an exclusive agreement for the distribution of its 'EarlyCDT-Lung' test kit in Portugal with Sabartech, its existing distributor in Spain, it announced on Friday.

Read more
5 Apr 2019 10:04

Oncimmune Signs Lung Cancer Test Kit Distribution Deal With Sabartech

LONDON (Alliance News) - Cancer diagnostics company Oncimmune Holdings PLC on Friday said it has signed an exclusive agreement for the distribution of its lung cancer test kit in Portgual with can

Read more
2 Apr 2019 10:50

Oncimmune strengthens scientific board with addition of Parag Mallick

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the appointment of Dr Parag Mallick - an associate professor of radiology at Stanford University - to its scientific board on Tuesday.

Read more
19 Mar 2019 12:19

Oncimmune Buys Protagen Diagnostics In EUR4 Million All-Share Deal (ALLISS)

LONDON (Alliance News) - Cancer testing firm Oncimmune Holdings PLC said Tuesday it acquired protein biomarker laboratory Protagen Diagnostics AG for EUR4.1 million in an all-share will buy the of

Read more
19 Mar 2019 09:10

Oncimmune acquires Protagen Diagnostics in £4.11m deal

(Sharecast News) - Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4.11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.

Read more
13 Feb 2019 10:45

Oncimmune Loss Widens In First Half On Administrative Costs

LONDON (Alliance News) - Cancer diagnostics business Oncimmune Holdings PLC on Wednesday said its loss widened in the first half its year on higher administrative expenses.In the six months

Read more
13 Feb 2019 09:20

Oncimmune Holdings' loss deepens on spiralling costs

(Sharecast News) - Oncimmune Holdings reported a widened interim loss on Wednesday as increases to research & development costs and administrative costs outweighed a rise in revenue.

Read more
20 Dec 2018 16:27

Oncimmune buoyed by US distribution deal for blood tests

(Sharecast News) - Oncimmune Holdings made gains on Thursday after it entered an agreement with America's Choice Provider Network to expand access to its EarlyCDT-Lung and EarlyCDT-Liver blood tests.

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
28 Nov 2018 11:57

Oncimmune signs sales deals in multiple countries for 'EarlyCDT-Lung' test

(Sharecast News) - Immunodiagnostics developer Oncimmune Holdings has signed exclusive agreements for the distribution of its 'EarlyCDT-Lung' test in Germany with hrmed.tech, in France with Eurobio Scientific, and in Italy with BSN, it announced on Wednesday.

Read more
31 Oct 2018 09:19

Oncimmune Annual Loss Deepens As Costs Hurt, Chases Cancer Test Deals

LONDON (Alliance News) - Oncimmune Holdings PLC said Wednesday its full year loss deepened on higher costs as it continues to chase new distribution deals for its cancer detection blood test the a

Read more
1 Oct 2018 12:47

Oncimmune inks multiple new distribution agreements

(Sharecast News) - Oncimmune revealed on Monday that it had signed multiple new distribution agreements for its EarlyCDT-Lung test as part of an early morning trading update.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.